Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
2008 pubmed 28 citations

Expression of the metastasis suppressor gene KISS1 in uveal melanoma.

Martins. C M O CM; Fernandes. B F BF; Antecka. E E; Di Cesare. S S; Mansure. J J C JJ; Marshall. J-C JC; Burnier. M N MN

Key Findings

  • KISS1 protein was detected in 84% of uveal melanoma tissue samples.
  • Low KISS1 expression correlated with a higher risk of metastasis.
  • Both KISS1 and its receptor GPR54 were expressed in all five melanoma cell lines studied.

Practical Outcomes

  • The study provides insight into KISS1 as a potential prognostic marker for eye melanoma, but it does not offer any actionable advice for health optimization, longevity, or performance enhancement. There are no dosing recommendations or therapeutic protocols for kisspeptin-10 that can be applied by biohackers based on these findings.

Summary

Researchers looked at a gene called KISS1, which can suppress cancer spread, in eye melanoma tumors. They found that most tumors had KISS1 protein, but lower levels were linked to a higher chance of the cancer spreading. The gene and its receptor were also present in melanoma cell lines.

Abstract

Uveal melanoma (UM) is the most common primary malignant intraocular tumour in adults. Forty-five percent of UM patients develop metastasis within 15 years of initial diagnosis. KISS1, a human metastasis suppressor gene, has been reported to play a role in various human malignancies. The purpose of this study was to investigate the expression of KISS1 in UM and its potential value as a prognostic marker. Thirty-seven cases of paraffin-embedded human UM specimens were immunostained with a KISS1 antibody. Clinical-pathological data were obtained. The relationship between the clinical-pathological data and the expression of KISS1 was evaluated. Moreover, the survival rates of the patients were also assessed. Five UM cell lines (92.1, OCM-1, MKTBR, UW1 and SP6.5) were assayed for KISS1 expression. In addition, real-time PCR was used to determine mRNA levels of KISS1and its receptor GPR54in these cell lines. The immunohistochemical results of KISS1 expression displayed cytoplasmic staining in 84% of UM specimens. Low KISS1 expression was associated with a higher risk of metastatic disease (P<0.05). Furthermore, we found that KISS1 was expressed in all five UM cells lines. Real-time PCR analysis confirmed the presence of both KISS1and its receptor GPR54in all five human UM cell lines. To the best of our knowledge, this is the first time that KISS1has been characterized in UM. The correlation between KISS1 expression and UM survival rate suggests an important role for KISS1as a prognostic marker in this particular tumour.

Study Information

Provider

pubmed

Year

2008

Date

2008-01-25T00:00:00.000Z

DOI

10.1038/sj.eye.6703090

Citations

28

References

30